Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Third Line Highly Active Antiretroviral Therapy (HAART) in HIV-infected Children

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2013 by The HIV Netherlands Australia Thailand Research Collaboration.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
Commission of higher education (CHE), Ministry of Education, Thailand
National Health Security Office, Thailand
Information provided by (Responsible Party):
Jintanat Ananworanich, The HIV Netherlands Australia Thailand Research Collaboration
ClinicalTrials.gov Identifier:
NCT01225406
First received: October 18, 2010
Last updated: February 7, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2013
  Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)